CTRC at the UT Health Science Center at San Antonio
San Antonio, Texas 78229
0 studies enrolling now · 6 studies all time
What they study most
Advanced Solid Tumors, Haematological Malignancies, Malignant Disease, Multiple Myeloma, Renal Cell Carcinoma
Studies at this site
- Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid Tumors — Completed
- Study of ACY-241 Alone and in Combination With Pomalidomide and Dexamethasone in Multiple Myeloma — Stopped early
- BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma — Completed
- ACY 241 in Combination With Paclitaxel in Patients With Advanced Solid Tumors — Completed
- Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma — Completed
- A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies — Stopped early